Effect of Denosumab vs Alendronate on Bone Turnover Markers and Bone Mineral Density Changes at 12 Months Based on Baseline Bone Turnover Level

Research output: Contribution to journalMeeting abstractContributedpeer-review

Contributors

Details

Original languageUndefined
JournalJournal of rheumatology
Publication statusPublished - 2009
Peer-reviewedYes

External IDs

WOS 000271593700133

Keywords